Skip to content

The effect of Comprehensive Medical and Invasive Treatment strategy for patients with significant Left Anterior Descending artery disease on plaque progression

The effect of Comprehensive Medical and Invasive Treatment strategy for patients with significant Left Anterior Descending artery disease on plaque progression - Plaque progression in diffusely diseased coronary arteries.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56133
Enrollment
100
Registered
2023-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease coronary heart disease

Interventions

None listed

Sponsors

Zuyderland Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Stable coronary artery disease OR Hemodynamically stable patients with a Non-STE Acute Coronary Syndrome Hemodynamically significant, diffuse LAD disease with involvement of the proximal segment (MEDINA 0.1.0 left main lesions allowed). Age >= 18. Signed informed consent. Ability to tolerate and no plans to interrupt relevant medical treatment during the duration of the study and willing to comply with protocol required follow-up.

Exclusion criteria

Exclusion criteria: Previous CABG Prior anterior myocardial infarction with clear evidence of residual akinesia and/or dyskinesia Extremely diseased LAD precluding intracoronary diagnostics or bypass grafting. Renal dysfunction (GFR

Design outcomes

Primary

MeasureTime frame
Disease progression and plaque burden. Patients will undergo a CT scan at baseline and at 1-year follow-up in order to estimate coronary calcification with the Agatston score and to analyse the progressions of stenotic lesions with a not pre-specified selection of methods.

Secondary

MeasureTime frame
Graft patency. Patients undergoing CABG will receive a baseline and follow-up (at 1-year) CT scan. There is no pre-specified scanning protocol.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)